[Webinar] Value Assessment in the Age of COVID-19
ISPOR, the Innovation and Value Initiative (IVI), and a panel of distinguished experts collaborate in this webinar series to define [...]
Industry Balks at Favored Nations Order
After talks broke down with the pharmaceutical industry's major lobby, PhRMA, the White House announced its plan to move ahead [...]
iHEA Accepting Abstract submissions for 2021 Congress
iHEA is pleased to invite you to join us virtually in July 2021 for the 14th World Congress on Health [...]
[Podcast] What Are the Implications of Teladoc’s Acquisition of Livongo?
Join Bob Matthews and Dan O’Neill as they discuss how the Teledoc and Livongo merger will result in a consumer-centric, [...]
[Conference] Health Technology Assessment: Challenges and Lessons Learned in Asia
Health technology assessment (HTA) has historically been easier and more impactful from a decision-maker or single payer perspective. However, many [...]
Using Real-world Data to Replicate Randomized Clinical Trial Results
The FDA intends to issue guidance on using real-world evidence (RWE) to aid in decisions about product effectiveness. Currently, there [...]
Trump Card: New Executive Order to Lower U.S. Drug Prices
Acting on a campaign promise to lower prescription drug prices, President Trump signed an executive order on Sunday aiming to [...]
New Guide Explains Role of Regulatory Medical Writers
Regulatory writing is a specialist type of writing that supports the drug approval and development process. The role of the [...]
The QALY and Value Assessment Frameworks in the Asia-Pacific Context
Although the QALY (quality-adjusted life year) has been a useful metric over the past few decades, it is not without [...]
Call for Proposals: AMCP 2021
AMCP is inviting proposals for continuing pharmacy education (CPE) sessions to be presented at AMCP 2021 on April 13-16, 2021 [...]
Towards a More Human-centered Approach to Improving Care: the Chief Outcomes Officer
COVID-19 has underscored the need to take a proactive, holistic approach to patient needs. Yet few health care organizations feel [...]
[Webinar] What Factors Determine Drug Prices?
What are all the different factors that impact what a patient pays at the pharmacy counter? Join Dr. Robert Popovian, [...]
ICER’s Hall of Shame: The Ten Least Cost-Effective Drugs
Read more here.
MDIC Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices
The Medical Device Innovation Consortium (MDIC) released its report on of Best Practices for Communicating Benefit, Risk, and Uncertainty for [...]
How Medical Affairs Led Medical Education Benefits Patients
New article from the Medical Affairs Professional Society (MAPS) series, ELEVATE, details how patient outcomes are being optimized by Medical [...]
Benefits–Not Just Costs–of Medicines Must Be a Part of Discussion
According to Dr. Robert W. Dubois, Interim President and CEO of NPC, in the context of healthcare costs, the amount [...]
New Study Examines Perspective and Costing in Cost-Effectiveness Analysis
A recent study examined perspective and costing approaches used in cost-effectiveness analyses (CEAs) and the distribution of reported incremental cost-effectiveness [...]
Balancing Research Needs and Big Data Security in Europe
Optimal allocation of limited resources depends upon development of sound evidence demonstrating ‘value for money’ and is thus a critical [...]
HTA in the USA: ICER vs NICE
The Institute for Clinical and Economic Review (ICER) has a reputation for performing high-quality independent health technology assessments (HTAs) in [...]
Big Pharma’s Stealthy Efforts to Undermine ICER
The Institute for Clinical and Economic Review (ICER) wields considerable influence over drug prices by providing analysis of a medicine’s [...]
World’s Most Expensive Prescription Drug Shows Promise in Trial
Episalvan, an orphan drug for a condition called epidermolysis bullosa, is an EMA-approved drug for partial thickness wounds. Shortly after [...]
Applying Adult Learning Principles to Virtual Delivery of Medical Education
Medical education is just one of the many fields radically altered by the COVID-19 pandemic. Medical conferences were either canceled [...]
[Webinar] RWE’s moment: What COVID-19 means for you
The desire for new insights is driving the need for real-world evidence (RWE) across our industry. Join the latest Reuters [...]
New Survey Aims to Find Solutions to Most Pressing Pandemic Challenges
COVID-19 has drastically changed the healthcare landscape, leaving many in crisis mode wondering how to best handle this new reality. [...]
CMS Streamlines Compare Websites With New Care Compare Website
The Centers for Medicare & Medicaid Services (CMS) officially launched Care Compare, a patient-facing website streamlining all CMS Compare websites [...]